RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Abhijit Date to Drug Carriers

This is a "connection" page, showing publications Abhijit Date has written about Drug Carriers.
Connection Strength

2.618
  1. Date AA, Hanes J, Ensign LM. Nanoparticles for oral delivery: Design, evaluation and state-of-the-art. J Control Release. 2016 10 28; 240:504-526.
    View in: PubMed
    Score: 0.513
  2. Date AA, Destache CJ. A review of nanotechnological approaches for the prophylaxis of HIV/AIDS. Biomaterials. 2013 Aug; 34(26):6202-28.
    View in: PubMed
    Score: 0.416
  3. Date AA, Srivastava D, Nagarsenker MS, Mulherkar R, Panicker L, Aswal V, Hassan PA, Steiniger F, Thamm J, Fahr A. Lecithin-based novel cationic nanocarriers (LeciPlex) I: fabrication, characterization and evaluation. Nanomedicine (Lond). 2011 Oct; 6(8):1309-25.
    View in: PubMed
    Score: 0.371
  4. Date AA, Vador N, Jagtap A, Nagarsenker MS. Lipid nanocarriers (GeluPearl) containing amphiphilic lipid Gelucire 50/13 as a novel stabilizer: fabrication, characterization and evaluation for oral drug delivery. Nanotechnology. 2011 Jul 08; 22(27):275102.
    View in: PubMed
    Score: 0.362
  5. Date AA, Desai N, Dixit R, Nagarsenker M. Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances. Nanomedicine (Lond). 2010 Dec; 5(10):1595-616.
    View in: PubMed
    Score: 0.350
  6. Date AA, Patravale VB. Microemulsions: applications in transdermal and dermal delivery. Crit Rev Ther Drug Carrier Syst. 2007; 24(6):547-96.
    View in: PubMed
    Score: 0.267
  7. Date AA, Shibata A, Goede M, Sanford B, La Bruzzo K, Belshan M, Destache CJ. Development and evaluation of a thermosensitive vaginal gel containing raltegravir+efavirenz loaded nanoparticles for HIV prophylaxis. Antiviral Res. 2012 Dec; 96(3):430-6.
    View in: PubMed
    Score: 0.099
  8. Jain AS, Date AA, Pissurlenkar RR, Coutinho EC, Nagarsenker MS. Sulfobutyl ether(7) ?-cyclodextrin (SBE(7) ?-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity. AAPS PharmSciTech. 2011 Dec; 12(4):1163-75.
    View in: PubMed
    Score: 0.092
  9. Nagarsenker MS, Amin L, Date AA. Potential of cyclodextrin complexation and liposomes in topical delivery of ketorolac: in vitro and in vivo evaluation. AAPS PharmSciTech. 2008; 9(4):1165-70.
    View in: PubMed
    Score: 0.076
  10. Date AA, Nagarsenker MS. Design and evaluation of microemulsions for improved parenteral delivery of propofol. AAPS PharmSciTech. 2008; 9(1):138-45.
    View in: PubMed
    Score: 0.072
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support